Department of Reproductive Biology - Centre d'Etude et de Conservation des Oeufs et du Sperme Humain (CECOS), Centre Hospitalier Universitaire de Reims, Reims, France.
Department of Pathology, Hôpital de Hautepierre, Strasbourg, France.
Front Endocrinol (Lausanne). 2023 Aug 31;14:1158405. doi: 10.3389/fendo.2023.1158405. eCollection 2023.
Cancer treatments of the last decades improve the survival rate of children and adolescents. However, chemo- and radiotherapy result in gonadal damage, leading to acute ovarian failure and sterility. The preservation of fertility is now an integral part of care of children requiring gonadotoxic treatments. Ovarian tissue cryopreservation (OTC) is an effective fertility preservation option that allows long-term storage of primordial follicles, subsequent transplantation, and restoration of endocrine function and fertility. The efficacy of this technique is well-demonstrated in adults but the data are scarce for pediatric patients. Currently, OTC represents the only possibility of preserving the potential fertility in prepubertal girls.
This is a retrospective study of OTC practice of two French centers from January 2004 to May 2020. A total of 72 patients from pediatric units underwent cryopreservation of ovarian tissue before gonadotoxic therapy for malignant or non-malignant diseases. The ovarian cortex was cut into fragments and the number of follicles per square millimeter was evaluated histologically. The long-term follow-up includes survival rate and hormonal and fertility status.
The mean age of patients at OTC was 9.3 years [0.2-17] and 29.2% were postpubertal; 51 had malignant diseases and 21 had non-malignant diseases. The most frequent diagnoses included acute leukemia, hemoglobinopathies, and neuroblastoma. Indication for OTC was stem cell transplantation for 81.9% ( = 59) of the patients. A third of each ovary was collected for 62.5% ( = 45) of the patients, a whole ovary for 33.3% ( = 24) of the patients, and a third of one ovary for 4.2% ( = 3) of the patients. An average of 17 fragments [5-35] per patient was cryoconserved. A correlation was found between the age of the patients and the number of fragments ( < 0.001). More fragments were obtained from partial bilateral harvesting than from whole ovary harvesting ( < 0.05). Histological analysis of ovarian tissue showed a median of 6.0 primordial follicles/mm [0.0-106.5] and no malignant cells were identified. A negative correlation was found between age and follicular density ( < 0.001). Median post-harvest follow-up was 92 months [1-188]. A total of 15 girls had died, 11 were still under treatment for their pathology, and 46 were in complete remission. Of all patients, 29 (40.2%) were subjected to a hormonal status evaluation and 26 were diagnosed with premature ovarian insufficiency (POI) ( < 0.001). One patient had undergone thawed ovarian tissue transplantation.
OTC should be proposed to all girls with high risk of developing POI following gonadotoxic therapies in order to give them the possibility of fertility and endocrine restoration.
过去几十年的癌症治疗提高了儿童和青少年的存活率。然而,化疗和放疗会导致性腺损伤,导致急性卵巢衰竭和不育。现在,保护生育能力是需要性腺毒性治疗的儿童护理的一个组成部分。卵巢组织冷冻保存(OTC)是一种有效的生育力保存选择,可长期储存原始卵泡,随后进行移植,并恢复内分泌功能和生育能力。该技术在成年人中的疗效已得到充分证明,但儿科患者的数据有限。目前,OTC 是保护青春期前女孩潜在生育能力的唯一可能性。
这是法国两个中心的回顾性研究,时间为 2004 年 1 月至 2020 年 5 月。来自儿科病房的 72 名患者在接受恶性或非恶性疾病的性腺毒性治疗前进行了卵巢组织冷冻保存。卵巢皮质被切成碎片,并通过组织学评估每平方毫米的卵泡数量。长期随访包括生存率以及激素和生育状况。
患者接受 OTC 的平均年龄为 9.3 岁[0.2-17],29.2%处于青春期后;51 例患有恶性疾病,21 例患有非恶性疾病。最常见的诊断包括急性白血病、血红蛋白病和神经母细胞瘤。干细胞移植是 81.9%(59/72)患者接受 OTC 的指征。62.5%(45/72)的患者采集了卵巢的三分之一,33.3%(24/72)的患者采集了整个卵巢,4.2%(3/72)的患者采集了一个卵巢的三分之一。每位患者平均冷冻保存了 17 个[5-35]个碎片。患者的年龄与碎片数量呈正相关( < 0.001)。部分双侧采集获得的碎片比整个卵巢采集获得的碎片多( < 0.05)。卵巢组织的组织学分析显示,中位数为 6.0 个原始卵泡/mm[0.0-106.5],未发现恶性细胞。年龄与卵泡密度呈负相关( < 0.001)。采集后中位随访时间为 92 个月[1-188]。共有 15 名女孩死亡,11 名仍在接受疾病治疗,46 名处于完全缓解期。所有患者中有 29 名(40.2%)接受了激素状态评估,其中 26 名被诊断为卵巢早衰(POI)( < 0.001)。一名患者接受了解冻卵巢组织移植。
对于接受性腺毒性治疗后有发生 POI 高风险的所有女孩,应建议进行 OTC,以便为她们提供生育和内分泌恢复的可能性。